AlphaFold predicted structure
SLC25A21 · Q9BQT8

Mean pLDDT
88.8/ 100
Confident
299 residues
Confidence breakdown
- Very high(≥ 90)57%
- Confident(70–90)39%
- Low(50–70)3%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
solute carrier family 25 member 21
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Mitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalLimb disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownmitochondrial DNA depletion syndrome 18
vertebral disorder
vertebral column disorder
Paralysis
Back pain
urolithiasis
lobe attachment
tooth disorder
vertebral joint disorder
alcohol drinking
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Mitochondrial 2-oxodicarboxylate carrier
Transports dicarboxylates across the inner membranes of mitochondria by a counter-exchange mechanism (PubMed:11083877). Can transport 2-oxoadipate (2-oxohexanedioate), 2-oxoglutarate, adipate (hexanedioate), glutarate, and to a lesser extent, pimelate (heptanedioate), 2-oxopimelate (2-oxoheptanedioate), 2-aminoadipate (2-aminohexanedioate), oxaloacetate, and citrate (PubMed:11083877). Plays a central role in catabolism of lysine, hydroxylysine, and tryptophan, by transporting common metabolite intermediates (such as 2-oxoadipate) into the mitochondria, where it is converted into acetyl-CoA and can enter the citric acid (TCA) cycle (Probable)
SLC25A21 · Q9BQT8

Mean pLDDT
88.8/ 100
Confident
299 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0